Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-10-09

Clinical Trial Update: The COMPASSION Study [NA]

View source ↗

Summary

The COMPASSION Study is currently recruiting for breast cancer, including metastatic, advanced, and unresectable forms.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Breast Cancer, Metastatic Breast Cancer | NA | Status: RECRUITING